Cancer-derived IgG involved in cisplatin resistance through PTP-BAS/Src/PDK1/AKT signaling pathway

Lu-Ming Wang1,2, Ye-Hua Gan1,2

  • 1Central Laboratory, Peking University School and Hospital of Stomatology, Beijing, China.

Oral Diseases
|July 31, 2020
PubMed
Abstract

Insights

Knocking down cancer-derived IgG (CIgG) enhances cisplatin

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Cancer-derived IgG (CIgG) plays a role in tumor progression.
  • Cisplatin is a common chemotherapy agent with limited efficacy in some oral cancers.

Purpose of the Study:

  • To investigate if CIgG knockdown potentiates cisplatin's anti-cancer effects.
  • To elucidate the molecular mechanisms underlying this interaction in oral squamous cell carcinoma.

Main Methods:

  • CIgG knockdown using siRNA and shRNA in oral cancer cell lines (WSU-HN6, CAL27).
  • Assessment of cell proliferation, apoptosis, migration, and invasion.
  • Analysis of molecular signaling pathways (AKT, PDK1, Src, PTP-BAS) via PCR and Western blot.

Main Results:

  • CIgG knockdown significantly enhanced cisplatin-induced apoptosis and inhibited proliferation, migration, and invasion.
  • CIgG knockdown reversed cisplatin-induced activation of the Src/PDK1/AKT pathway and modulated PTP-BAS expression.
  • The PTP-BAS/Src/PDK1/AKT pathway is crucial for CIgG's influence on cisplatin efficacy.

Conclusions:

  • CIgG knockdown is a promising strategy to enhance cisplatin's anti-cancer activity in oral squamous cell carcinoma.
  • Targeting the PTP-BAS/Src/PDK1/AKT pathway may overcome cisplatin resistance.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.4K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K